These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9021525

  • 1. Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats.
    Yamamoto M, Fukui M, Shou I, Wang LN, Sekizuka K, Suzuki S, Shirato I, Tomino Y.
    J Clin Lab Anal; 1997; 11(1):53-62. PubMed ID: 9021525
    [Abstract] [Full Text] [Related]

  • 2. Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure.
    Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, Fogo A.
    Kidney Int; 1992 Jul; 42(1):46-55. PubMed ID: 1635354
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
    Oikawa T, Freeman M, Lo W, Vaughan DE, Fogo A.
    Kidney Int; 1997 Jan; 51(1):164-72. PubMed ID: 8995730
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis.
    Amann K, Irzyniec T, Mall G, Ritz E.
    J Hypertens; 1993 Sep; 11(9):969-75. PubMed ID: 8254179
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model.
    Raij L, Chiou XC, Owens R, Wrigley B.
    Am J Med; 1985 Sep 27; 79(3C):37-41. PubMed ID: 2996345
    [Abstract] [Full Text] [Related]

  • 14. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.
    Adamczak M, Gross ML, Amann K, Ritz E.
    J Am Soc Nephrol; 2004 Dec 27; 15(12):3063-72. PubMed ID: 15579509
    [Abstract] [Full Text] [Related]

  • 15. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure.
    Ziai F, Ots M, Provoost AP, Troy JL, Rennke HG, Brenner BM, Mackenzie HS.
    Kidney Int Suppl; 1996 Dec 27; 57():S132-6. PubMed ID: 8941934
    [Abstract] [Full Text] [Related]

  • 16. Renal protective effects of blocking the intrarenal renin-angiotensin system: angiotensin II type I receptor antagonist compared with angiotensin-converting enzyme inhibitor.
    Zhou A, Yu L, Li J, Zhang J, Wang H.
    Hypertens Res; 2000 Jul 27; 23(4):391-7. PubMed ID: 10912779
    [Abstract] [Full Text] [Related]

  • 17. Renin-angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.
    Sedláková L, Čertíková Chábová V, Doleželová Š, Škaroupková P, Kopkan L, Husková Z, Červenková L, Kikerlová S, Vaněčková I, Sadowski J, Kompanowska-Jezierska E, Kujal P, Kramer HJ, Červenka L.
    Clin Exp Hypertens; 2017 Jul 27; 39(2):183-195. PubMed ID: 28287881
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of enalapril and irbesartan in experimental papillary necrosis.
    Garber SL, Mirochnik Y, Arruda JA, Dunea G, Slobodskoy L.
    Kidney Blood Press Res; 2001 Jul 27; 24(1):39-43. PubMed ID: 11174005
    [Abstract] [Full Text] [Related]

  • 19. Urinary transforming growth factor-beta (TGF-beta) excretion and renal production of TGF-beta in rats with subtotal renal ablation: effect of enalapril and nifedipine.
    Monteiro de Freitas AS, Coimbra TM, Costa RS, Baroni EA.
    Nephron; 1998 Jul 27; 78(3):302-9. PubMed ID: 9546691
    [Abstract] [Full Text] [Related]

  • 20. Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition.
    Kon V, Fogo A, Ichikawa I.
    Kidney Int; 1993 Sep 27; 44(3):545-50. PubMed ID: 8231026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.